Literature DB >> 18381507

Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.

Daniel J Merenstein1, Michael F Schneider, Christopher Cox, Rebecca Schwartz, Kathleen Weber, Esther Robison, Monica Gandhi, Jean Richardson, Michael W Plankey.   

Abstract

OBJECTIVE: The purpose of this work was to evaluate whether living with children adversely affects adherence to highly active antiretroviral therapy in HIV-infected women. PARTICIPANTS AND METHODS: We conducted a prospective cohort study between October 1998 and September 2005. The study outcome was > or = 95% adherence to highly active antiretroviral therapy evaluated at 5832 semiannual visits among 1366 HIV-infected women in the Women's Interagency HIV Study. The primary exposure defined at the visit immediately before outcome ascertainment was the number of children < or = 18 years of age reported living in the household.
RESULTS: The percentage of women who reported > or = 2 children in the household who also reported > or = 95% adherence ranged from 68% to 75% compared with adherence when either 1 child or no children were reported. Each additional child reported living in the household was associated with a 6% decrease in the odds of > or = 95% adherence.
CONCLUSION: The impact of living with a child on the ability to take medications by HIV-infected women has not been examined thoroughly. Our data suggest that adherence to highly active antiretroviral therapy is inversely associated with the number of children living in the household.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381507      PMCID: PMC2651400          DOI: 10.1542/peds.2007-1586

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

Review 1.  Improving treatment adherence in drug abusers who are HIV-positive.

Authors:  S B Malone; J J Osborne
Journal:  Lippincotts Case Manag       Date:  2000 Nov-Dec

Review 2.  Measuring adherence to highly active antiretroviral therapy: implications for research and practice.

Authors:  Thomas Kerr; John Walsh; Elisa Lloyd-Smith; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

Review 3.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Authors:  Lynn M Kirstein; Ruth M Greenblatt; Kathryn Anastos; Alexandra Levine; Audrey L French; Howard Minkoff; Sylvia Silver; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

6.  Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus.

Authors:  Tracey E Wilson; Yolanda Barrón; Mardge Cohen; Jean Richardson; Ruth Greenblatt; Henry S Sacks; Mary Young
Journal:  Clin Infect Dis       Date:  2002-01-09       Impact factor: 9.079

7.  Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

Authors:  P T Nieuwkerk; M A Sprangers; D M Burger; R M Hoetelmans; P W Hugen; S A Danner; M E van Der Ende; M M Schneider; G Schrey; P L Meenhorst; H G Sprenger; R H Kauffmann; M Jambroes; M A Chesney; F de Wolf; J M Lange
Journal:  Arch Intern Med       Date:  2001-09-10

8.  Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.

Authors:  C Laine; C J Newschaffer; D Zhang; L Cosler; W W Hauck; B J Turner
Journal:  Obstet Gynecol       Date:  2000-02       Impact factor: 7.661

9.  Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women.

Authors:  Judith A Cook; Mardge H Cohen; Dennis Grey; Lynn Kirstein; Jane Burke; Kathryn Anastos; Herminia Palacio; Jean Richardson; Tracey E Wilson; Mary Young
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

10.  Maternal disclosure of mothers' HIV serostatus to their young children.

Authors:  D A Murphy; W N Steers; M E Dello Stritto
Journal:  J Fam Psychol       Date:  2001-09
View more
  6 in total

Review 1.  Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.

Authors:  Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

2.  Predictors of medication adherence among HIV-positive women in North America.

Authors:  Lynda A Tyer-Viola; Inge B Corless; Alison Webel; Paula Reid; Kathleen M Sullivan; Patrice Nichols
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2014-02-06

3.  Follow-up care among HIV-infected pregnant women in Mississippi.

Authors:  Aadia I Rana; Fizza S Gillani; Timothy P Flanigan; Binford T Nash; Curt G Beckwith
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

4.  Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most.

Authors:  Morgan M Philbin; Sadie Bergen; Carrigan Parish; Deanna Kerrigan; Elizabeth N Kinnard; Sarah Reed; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Michael Vaughn; José I Gutierrez; Margaret A Fischl; Maria Alcaide; Lisa R Metsch
Journal:  AIDS Behav       Date:  2021-10-14

5.  Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.

Authors:  Daniel Merenstein; Michael F Schneider; Christopher Cox; Rebecca Schwartz; Kathleen Weber; Esther Robison; Monica Gandhi; Jean Richardson; Michael W Plankey
Journal:  AIDS Patient Care STDS       Date:  2009-04       Impact factor: 5.078

Review 6.  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.

Authors:  Jean B Nachega; Olalekan A Uthman; Jean Anderson; Karl Peltzer; Sarah Wampold; Mark F Cotton; Edward J Mills; Yuh-Shan Ho; Jeffrey S A Stringer; James A McIntyre; Lynne M Mofenson
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.